Wikidata entity: Q45050
C₁₃H₁₁N₃O₄S₂ (P274)

Quantities
| P4250 | defined daily dose | 20 |
| P2067 | mass | 337.019 |
| P233 | canonical SMILES | String | CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3 | ??? |
| P373 | Commons category | String | Tenoxicam | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q682 (sulfur) | sulfur |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P1987 | MCN code | String | 2935.90.24 | ??? |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q190016 (heparin) | heparin |
| P769 | significant drug interaction | ... | Q221520 (triamterene) | triamterene |
| P769 | significant drug interaction | ... | Q155472 (valsartan) | valsartan |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q275926 (bumetanide) | bumetanide |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410074 (losartan) | losartan |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q412050 (prostacyclin) | prostacyclin |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q416132 (betamethasone) | betamethasone |
| P769 | significant drug interaction | ... | Q416232 (prasugrel) | prasugrel |
| P769 | significant drug interaction | ... | Q415220 (pemetrexed) | pemetrexed |
| P769 | significant drug interaction | ... | Q415366 (tirofiban) | tirofiban |
| P769 | significant drug interaction | ... | Q415970 (candesartan) | candesartan |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q419995 (amiloride) | amiloride |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q421156 (olmesartan) | olmesartan |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422188 (spironolactone) | spironolactone |
| P769 | significant drug interaction | ... | Q422212 (budesonide) | budesonide |
| P769 | significant drug interaction | ... | Q422232 (methotrexate) | methotrexate |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q423804 (eplerenone) | eplerenone |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q733186 (telmisartan) | telmisartan |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q1640947 (phenindione) | phenindione |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q784717 (eprosartan) | eprosartan |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q947266 (irbesartan) | irbesartan |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q1169164 ((RS)-bendroflumethiazide) | (RS)-bendroflumethiazide |
| P769 | significant drug interaction | ... | Q2295855 (eptifibatide) | eptifibatide |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q20817252 (tinzaparin) | tinzaparin |
| P769 | significant drug interaction | ... | Q27074832 (azilsartan) | azilsartan |
| P769 | significant drug interaction | ... | Q27077698 (fondaparinux) | fondaparinux |
| P769 | significant drug interaction | ... | Q27132753 (tenofovir disoproxil) | tenofovir disoproxil |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q3655338 (cangrelor) | cangrelor |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q20817139 (iloprost) | iloprost |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q188724 (non-steroidal anti-inflammatory drug) | non-steroidal anti-inflammatory drug |
| P2868 | subject has role | ... | Q20522059 (cyclooxygenase inhibitors) | cyclooxygenase inhibitors |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | tenoxicam | ??? |
| P267 | ATC code | M01AC02 |
| P231 | CAS Registry Number | 59804-37-4 |
| P683 | ChEBI ID | 32192 |
| P592 | ChEMBL ID | CHEMBL302795 |
| P661 | ChemSpider ID | 10442339 |
| P715 | DrugBank ID | DB00469 |
| P11198 | DrugCentral ID | 2595 |
| P8494 | DSSTOX compound identifier | DTXCID6025486 |
| P3117 | DSSTox substance ID | DTXSID8045486 |
| P232 | EC number | 620-500-8 |
| P2566 | ECHA Substance Infocard ID | 100.149.365 |
| P646 | Freebase ID | /m/03cb9hz |
| P4168 | IEDB Epitope ID | 613457 |
| P234 | InChI | InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18) |
| P235 | InChIKey | LZNWYQJJBLGYLT-UHFFFAOYSA-N |
| P665 | KEGG ID | D01767 |
| P486 | MeSH descriptor ID | C032801 |
| P6366 | Microsoft Academic ID (discontinued) | 2778432687 |
| P2840 | NSC number | 758397 |
| P10283 | OpenAlex ID | C2778432687 |
| P11199 | Probes And Drugs ID | PD001061 |
| P662 | PubChem CID | 54677971 |
| P1579 | Reaxys registry number | 572193 |
| P3345 | RxNorm CUI | 37790 |
| P5076 | Römpp online ID | RD-20-00647 |
| P2877 | SureChEMBL ID | 25343 |
| P11089 | UniChem compound ID | 902707 |
| P652 | UNII | Z1R9N0A399 |
Why not click here or view trends?
log id: 1877757